About
Small Molecules
Areas of Focus
Categories
Small Molecule Pharmaceutical
Team (2)
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
119
By Phase
EARLY_PHASE1: 1PHASE1/PHASE2: 1PHASE1: 1
By Status
NOT_YET_RECRUITING: 1RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT07213882Collaborator
A Phase 1, Multicenter, Open-label, Prospective, First-in-human Dose-escalation Clinical Trial of Domain Therapeutics' Anti-CCR8 Monoclonal Antibody (DT-7012) in Patients With Relapsed or Refractory Cutaneous T-cell Lymphomas (CTCL)
EARLY_PHASE1Not yet recruiting
30 participants
Started: Jan 1, 2026 · Completed: Aug 1, 2028
NCT06819735Collaborator
Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
60 participants
Started: Jun 25, 2025 · Completed: Jan 31, 2028
NCT05582850Lead Sponsor
DT-9081 Study in Participants With Advanced, Recurrent or Metastatic Solid Tumours
PHASE1Completed
29 participants
Started: Nov 24, 2022 · Completed: Jul 28, 2025
Locations (1)
Headquarters
Illkirch-Strasbourg, France
Map
Loading map...